| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-07-0312 |
| P698 | PubMed publication ID | 17909008 |
| P50 | author | Jens Hansen | Q56678925 |
| W. Wurst | Q67390467 | ||
| P2093 | author name string | Saverio Minucci | |
| Thomas Floss | |||
| Stephan Zimmermann | |||
| Martin Göttlicher | |||
| Carmen Spiller | |||
| Franz Kiefer | |||
| Michela Prudenziati | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9047-9054 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice | |
| P478 | volume | 67 |
| Q34065056 | A novel class of small molecule inhibitors of HDAC6. |
| Q38712941 | A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog. |
| Q38108666 | CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy now |
| Q34488391 | Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humans |
| Q36909814 | Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. |
| Q42757408 | Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis. |
| Q28283633 | Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function |
| Q37521097 | Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models. |
| Q37835686 | Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action |
| Q36515818 | Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier |
| Q37567572 | Epigenetic therapeutics in autoimmune disease |
| Q36481113 | Essential Nonredundant Function of the Catalytic Activity of Histone Deacetylase 2 in Mouse Development |
| Q37194816 | Genetic dissection of histone deacetylase requirement in tumor cells |
| Q37098834 | HDAC1 and HDAC2 in mouse oocytes and preimplantation embryos: Specificity versus compensation |
| Q28577473 | HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs |
| Q33897677 | HDAC2 promotes eIF4E sumoylation and activates mRNA translation gene specifically |
| Q36966883 | HDAC3 is essential for DNA replication in hematopoietic progenitor cells. |
| Q36296735 | HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis. |
| Q46477219 | Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation |
| Q64998522 | Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. |
| Q36146330 | Histone Deacetylases in Bone Development and Skeletal Disorders. |
| Q40382280 | Histone H3K9 Acetyltransferase PCAF Is Essential for Osteogenic Differentiation Through Bone Morphogenetic Protein Signaling and May Be Involved in Osteoporosis |
| Q37970955 | Histone acetyltransferases and deacetylases: molecular and clinical implications to gastrointestinal carcinogenesis |
| Q24603793 | Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy |
| Q33929178 | Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation |
| Q48268665 | Histone deacetylase 1 and 2 are essential for murine neural crest proliferation, pharyngeal arch development, and craniofacial morphogenesis. |
| Q28571005 | Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins |
| Q38796545 | Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription |
| Q41033936 | Histone deacetylase inhibition impairs normal intestinal cell proliferation and promotes specific gene expression |
| Q28505369 | Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription |
| Q37325492 | Histone deacetylase inhibitors as novel anticancer therapeutics. |
| Q39247455 | Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression |
| Q38459887 | Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers |
| Q38240733 | Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders |
| Q38020758 | Histone deacetylases in kidney development: implications for disease and therapy |
| Q34612849 | Histone deacetylases in skeletal development and bone mass maintenance |
| Q38215303 | Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors |
| Q37262437 | Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development |
| Q34252732 | Ketone bodies as signaling metabolites. |
| Q34124934 | Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy |
| Q39306981 | MYC-Master Regulator of the Cancer Epigenome and Transcriptome |
| Q42737863 | Making sense of HDAC2 mutations in colon cancer |
| Q38747135 | Metal-dependent Deacetylases: Cancer and Epigenetic Regulators |
| Q38017096 | Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes |
| Q37979639 | Multiple roles of class I HDACs in proliferation, differentiation, and development |
| Q102317286 | Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity |
| Q34540661 | Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction |
| Q37656544 | On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling |
| Q37477736 | Open chromatin in pluripotency and reprogramming |
| Q33390343 | Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis |
| Q53292303 | Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. |
| Q33888552 | Retinoic acid and histone deacetylases regulate epigenetic changes in embryonic stem cells |
| Q64039896 | Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer |
| Q42555454 | Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors |
| Q47861273 | Sin3a regulates epithelial progenitor cell fate during lung development |
| Q38051736 | Targeting class I histone deacetylases in cancer therapy |
| Q53201323 | Targeting the epigenome for treatment of cancer. |
| Q29619117 | The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men |
| Q33648852 | The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. |
| Q44650692 | The expression of HDAC1 and HDAC2 during cerebellar cortical development. |
| Q24628821 | The many roles of histone deacetylases in development and physiology: implications for disease and therapy |
| Q48238401 | The specific role of histone deacetylase 2 in adult neurogenesis. |
| Q38156341 | Transcription and beyond: the role of mammalian class I lysine deacetylases |
| Q38341800 | Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects |
| Q39465533 | VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin |
| Q38724987 | Valproic acid (VPA) enhances cisplatin sensitivity of non-small cell lung cancer cells via HDAC2 mediated down regulation of ABCA1. |
| Q39311565 | β-Hydroxybutyrate: A Signaling Metabolite. |
| Q35553084 | β-hydroxybutyrate: much more than a metabolite |
Search more.